Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.

Fujita T, Kutsumi H, Sanuki T, Hayakumo T, Azuma T.

J Gastroenterol. 2013 May;48(5):559-73. doi: 10.1007/s00535-013-0771-8. Epub 2013 Mar 5. Review.

2.

Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.

Scheiman JM, Hindley CE.

Clin Ther. 2010 Apr;32(4):667-77. doi: 10.1016/j.clinthera.2010.04.009. Review.

PMID:
20435236
3.

Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.

Warlé-van Herwaarden MF, Koffeman AR, Valkhoff VE, 't Jong GW, Kramers C, Sturkenboom MC, De Smet PA.

Br J Clin Pharmacol. 2015 Sep;80(3):589-98. doi: 10.1111/bcp.12626. Epub 2015 May 22.

4.
5.
6.
7.

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):481-96. doi: 10.1111/j.1365-2036.2008.03905.x. Epub 2008 Nov 27.

8.

Strategies to reduce the GI risks of antiplatelet therapy.

Scheiman JM.

Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Review.

PMID:
17710073
9.

Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.

Hachiken H, Murai A, Wada K, Kuwahara T, Hosomi K, Takada M.

Int J Clin Pharmacol Ther. 2013 Oct;51(10):807-15. doi: 10.5414/CP201914.

PMID:
24040850
10.

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D.

BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. Review.

11.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

PMID:
14585915
12.

Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding.

Iwamoto J, Mizokami Y, Saito Y, Shimokobe K, Honda A, Ikegami T, Matsuzaki Y.

World J Gastroenterol. 2014 Sep 28;20(36):13133-8. doi: 10.3748/wjg.v20.i36.13133.

14.
15.

NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.

Pilotto A, Franceschi M, Leandro G, Di Mario F; Geriatric Gastroenterology Study Group (Societè Italiana Gerontologie Geriatria).

Drugs Aging. 2003;20(9):701-10.

PMID:
12831293
17.

Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care.

Lanas A, Plazas MA, Gimeno E, Muñoz-Tudurí M.

Gastroenterol Hepatol. 2012 Jan;35(1):1-7. doi: 10.1016/j.gastrohep.2011.10.004. Epub 2011 Dec 16.

PMID:
22178503
18.

How to advise aspirin use in patients who need NSAIDs.

Sopena F, Lanas A.

Curr Pharm Des. 2007;13(22):2248-60. Review.

PMID:
17691998
19.

Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.

Hedberg J, Sundström J, Thuresson M, Aarskog P, Oldgren J, Bodegard J.

J Intern Med. 2013 Oct;274(4):371-80. doi: 10.1111/joim.12103. Epub 2013 Jul 10.

20.

Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.

Shiotani A, Manabe N, Kamada T, Fujimura Y, Sakakibara T, Haruma K.

J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:8-12. doi: 10.1111/j.1440-1746.2012.07071.x. Review.

PMID:
22486865

Supplemental Content

Support Center